中州證券(01375.HK)2023年度計提資產減值準備共計6733.39萬元
格隆匯1月30日丨中州證券(01375.HK)發佈公吿,根據《企業會計準則》和公司會計政策的相關規定,為準確、客觀地反映公司2023年12月31日的財務狀況及2023年度的經營成果,經公司及下屬子公司對各項金融資產、存貨和長期資產等進行全面清查和減值測試,2023年度計提信用減值準備人民幣5,428.98萬元,計提其他資產減值準備人民幣1,304.41萬元,合計人民幣6,733.39萬元。
公司2023年度合併報表計提資產減值準備共計人民幣6,733.39萬元,減少2023年度利潤總額人民幣6,733.39萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.